News Releases

Guerbet (GBT) a global leader in medical imaging, will demonstrate its product portfolio during a highlights demonstration at RSNA 2020.

WHERE: Join the meeting through the RSNA virtual booth at www.rsna.org/annual-meeting or at https://www.guerbet.com/en-us/rsna-2020/

WHEN: Friday, December 4 from 2-2:30pm CT

WHAT: Guerbet will host a “Highlights Demonstration” at our virtual booth. The session will guide HCPs through Guerbet’s digital solution offerings across the patient experience to help close the loop with smart connectivity for monitoring and reporting. Products featured during the demonstration include:

• Dose&Care^®, a state-of-the-art digital solution to monitor patients’ exposure to radiation
• Contrast&Care^®, a next-level contrast media injection data management solution enabling imaging centers to collect, archive, examine and share data directly with Guerbet’s injectors to help radiologists with patient care
• IBM Watson Patient Synopsis, a radiologist-trained artificial intelligence tool that extracts relevant patient information and summarizes into a tailored and specific dashboard to help physicians make informed diagnostic decisions

Links will be available until April 2021. To learn more, visit Guerbet at www.rsna.org/annual-meeting or https://www.guerbet.com/en-us/rsna-2020/.

About Guerbet

Guerbet is a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. A pioneer since more than 90 years in the field of contrast media with over 2,800 people globally, Guerbet is continuously innovating with 9% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €817 million in revenue in 2019. For more information about Guerbet, please visit www.guerbet.com.